This inventor holds 6 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd., Mds Wellcome Trust Hilleman Laboratories Pvt. Ltd.. Active years: 2018-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
5 out of 6 
1 out of 1 Years Active: 2018-2021
Title: Davinder Gill: Innovator in Vaccine Development
Introduction
Davinder Gill is a prominent inventor based in New Delhi, India. He has made significant contributions to the field of vaccine development, holding a total of 6 patents. His work focuses on improving vaccine formulations and processes, particularly in relation to cholera and rotavirus.
Latest Patents
One of his latest patents is titled "Process for production of purified recombinant cholera toxin B (rCTB) and formulation thereon." This invention relates to a novel process that enhances the yield and purity of rCTB, which provides protection against diarrhea caused by various bacteria, including Enterotoxigenic E. coli (ETEC). Additionally, it includes a vaccine formulation that offers synergistic protection and cross-protection against ETEC.
Another significant patent is the "Thermostable spray dried rotavirus vaccine formulation and process thereof." This invention presents an improved thermostable vaccine formulation that can be prepared in liquid, powder, or granule form. The spray drying process enhances the heat stability, ease of use, and affordability of the vaccine, making it more suitable for vaccination programs in developing and low-income countries.
Career Highlights
Davinder Gill has worked with notable organizations such as MSD Wellcome Trust Hilleman Laboratories Pvt. Ltd. His experience in these companies has allowed him to contribute to groundbreaking research and development in the field of vaccines.
Collaborations
Throughout his career, Davinder has collaborated with talented individuals, including Tarun Sharma and Nidhi Shukla. These collaborations have further enriched his work and expanded the impact of his inventions.
Conclusion
Davinder Gill's innovative work in vaccine development has the potential to significantly improve public health, particularly in regions vulnerable to infectious diseases. His contributions through his patents reflect a commitment to advancing medical science and enhancing vaccine accessibility.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile